Exelon / Prometax (rivastigmine) - Important Safety Information from Novartis as approved by the Irish Medicines Board
04 May 2010
Important Safety Information communication from Novartis on the inappropriate use of and medication errors associated with Exelon® / Prometax® transdermal patch.
Important Safety Information - Exelon / Prometax (rivastigmine)